Hypothetical case - For market research purposes only
UNITED BY CANCER
About Us Our Treatments Our Science
Our Story Events Resources
Profile
Search
You are about to enter Our Science, which contains information concerning our Research & Development activities as well as other information produced by our Medical Affairs function.
You are about to enter Our Treatments, which contains information promoting the use of our approved medicines.

The DREAMM-3 Clinical Trial

Download pdf
[432 Kb]

Learn about DREAMM-3, an ongoing trial evaluating the efficacy and safety of single agent belantamab mafodotin-blmf when compared to pomalidomide plus low-dose dexamethasone in participants with RRMM

_

_